Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL28240977 | 0.99 | MAPT (0.50) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| Methacrylic Acid SCHEMBL1219584 | 0.99 | MAPT (0.50) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| Methacrylic Acid SCHEMBL1219581 | 0.99 | MAPT (0.50) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| Acetic Acid SCHEMBL27635724 | 0.94 | MAPT (0.51) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| Acetic Acid SCHEMBL8839883 | 0.94 | MAPT (0.51) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL23865155 | 0.94 | MAPT (0.53) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL20192085 | 0.94 | MAPT (0.53) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL7173571 | 0.94 | MAPT (0.53) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL20505978 | 0.94 | MAPT (0.53) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL7538065 | 0.94 | MAPT (0.53) | MAPTMAPK1KMT2ACYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1867664-B1 | COSMETIC FOR EYELASH | KAO CORP (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20090053270-A1 | COSMETIC FOR EYELASHES | KAO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1867664-A1 | COSMETIC FOR EYELASH | Kao Corporation (JP) | 2007-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090053270-A1 | COSMETIC FOR EYELASHES | MBNL1, MITF, SGPL1 | MAPT 536/4885MAPK1 795/4885KMT2A 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.